96 related articles for article (PubMed ID: 1646302)
1. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man.
Bakker WH; Krenning EP; Breeman WA; Kooij PP; Reubi JC; Koper JW; de Jong M; Laméris JS; Visser TJ; Lamberts SW
J Nucl Med; 1991 Jun; 32(6):1184-9. PubMed ID: 1646302
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
[TBL] [Abstract][Full Text] [Related]
3. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals.
Bakker WH; Krenning EP; Breeman WA; Koper JW; Kooij PP; Reubi JC; Klijn JG; Visser TJ; Docter R; Lamberts SW
J Nucl Med; 1990 Sep; 31(9):1501-9. PubMed ID: 1975618
[TBL] [Abstract][Full Text] [Related]
4. In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
Bakker WH; Krenning EP; Reubi JC; Breeman WA; Setyono-Han B; de Jong M; Kooij PP; Bruns C; van Hagen PM; Marbach P
Life Sci; 1991; 49(22):1593-601. PubMed ID: 1658516
[TBL] [Abstract][Full Text] [Related]
5. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
Bakker WH; Albert R; Bruns C; Breeman WA; Hofland LJ; Marbach P; Pless J; Pralet D; Stolz B; Koper JW
Life Sci; 1991; 49(22):1583-91. PubMed ID: 1658515
[TBL] [Abstract][Full Text] [Related]
6. Studies on radiolabeled somatostatin analogues in rats and in patients.
Breeman WA; Bakker WH; De Jong M; Hofland LJ; Kwekkeboom DJ; Kooij PP; Visser TJ; Krenning EP
Q J Nucl Med; 1996 Sep; 40(3):209-20. PubMed ID: 8961800
[TBL] [Abstract][Full Text] [Related]
7. Receptors on tumors studied with radionuclide scintigraphy.
Larson S
J Nucl Med; 1991 Jun; 32(6):1189-91. PubMed ID: 1646303
[No Abstract] [Full Text] [Related]
8. Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
Breeman WA; Hofland LJ; Bakker WH; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Kwekkeboom DJ; Visser TJ; Lamberts SW
Eur J Nucl Med; 1993 Nov; 20(11):1089-94. PubMed ID: 7904561
[TBL] [Abstract][Full Text] [Related]
9. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
10. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
[No Abstract] [Full Text] [Related]
12. Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin.
Krenning EP; Bakker WH; Breeman WA; Koper JW; Kooij PP; Ausema L; Lameris JS; Reubi JC; Lamberts SW
Lancet; 1989 Feb; 1(8632):242-4. PubMed ID: 2563413
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin-receptor imaging in the localization of endocrine tumors.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
[TBL] [Abstract][Full Text] [Related]
14. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Breeman WA; Lamberts SW
Endocrinology; 1995 Sep; 136(9):3698-706. PubMed ID: 7649075
[TBL] [Abstract][Full Text] [Related]
15. Pituitary imaging using a labelled somatostatin analogue in acromegaly.
Ur E; Mather SJ; Bomanji J; Ellison D; Britton KE; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1992 Feb; 36(2):147-50. PubMed ID: 1348978
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.
Breeman WA; de Jong M; Bernard B; Hofland LJ; Srinivasan A; van der Pluijm M; Bakker WH; Visser TJ; Krenning EP
Anticancer Res; 1998; 18(1A):83-9. PubMed ID: 9568060
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of somatostatin receptor imaging.
Reichlin S
J Clin Endocrinol Metab; 1990 Sep; 71(3):564-5. PubMed ID: 2168429
[No Abstract] [Full Text] [Related]
18. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
[No Abstract] [Full Text] [Related]
19. Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors.
Stolz B; Smith-Jones PM; Albert R; Reist H; Mäcke H; Bruns C
Horm Metab Res; 1994 Oct; 26(10):453-9. PubMed ID: 7851867
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
Krenning EP; Kwekkeboom DJ; Oei HY; Reubi JC; van Hagen PM; Kooij PP; Reijs AE; Lamberts SW
Schweiz Med Wochenschr; 1992 Apr; 122(17):634-7. PubMed ID: 1350377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]